Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients

Published Date: 25 Dec 2024

Recent results from the Phase III NRG-RTOG 1112 clinical study showed that the addition of stereotactic body radiotherapy (SBRT) to systemic therapy with sorafenib significantly improved progression-free survival (PFS) and ...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Survivors of childhood brain cancer are more likely to be held back in school

2.

Trump slashed US cancer research by 31 percent: Senate report

3.

Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus

4.

New research uncovers link between cancer pathway and blood-retina barrier function

5.

CAR-T cell therapy for cancer causes 'brain fog,' study shows


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot